{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T16:58:27Z","timestamp":1763398707451},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Syst Biol"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1752-0509-8-82","type":"journal-article","created":{"date-parts":[[2014,7,7]],"date-time":"2014-07-07T13:02:05Z","timestamp":1404738125000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Integrative analysis of differential miRNA and functional study of miR-21 by seed-targeting inhibition in multiple myeloma cells in response to berberine"],"prefix":"10.1186","volume":"8","author":[{"given":"Xiaochuang","family":"Luo","sequence":"first","affiliation":[]},{"given":"Jingyi","family":"Gu","sequence":"additional","affiliation":[]},{"given":"Rongxuan","family":"Zhu","sequence":"additional","affiliation":[]},{"given":"Maoxiao","family":"Feng","sequence":"additional","affiliation":[]},{"given":"Xuejiao","family":"Zhu","sequence":"additional","affiliation":[]},{"given":"Yumin","family":"Li","sequence":"additional","affiliation":[]},{"given":"Jia","family":"Fei","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2014,7,7]]},"reference":[{"issue":"9686","key":"1347_CR1","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/S0140-6736(09)60221-X","volume":"374","author":"MS Raab","year":"2009","unstructured":"Raab MS, Podar K, Breitkreutz I, Richardson PG, Anderson KC: Multiple myeloma. Lancet. 2009, 374 (9686): 324-339. 10.1016\/S0140-6736(09)60221-X.","journal-title":"Lancet"},{"issue":"1\u20132","key":"1347_CR2","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1002\/prca.201000044","volume":"5","author":"F Ge","year":"2011","unstructured":"Ge F, Bi LJ, Tao SC, Xu XD, Zhang ZP, Kitazato K, Zhang XE: Proteomic analysis of multiple myeloma: current status and future perspectives. Proteomics Clin Appl. 2011, 5 (1\u20132): 30-37.","journal-title":"Proteomics Clin Appl"},{"issue":"4","key":"1347_CR3","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1158\/0008-5472.CAN-03-2876","volume":"64","author":"R Fonseca","year":"2004","unstructured":"Fonseca R, Barlogie B, Bataille R, Bastard C, Bergsagel PL, Chesi M, Davies FE, Drach J, Greipp PR, Kirsch IR, Kuehl WM, Hernandez JM, Minvielle S, Pilarski LM, Shaughnessy JD, Stewart AK, Avet-Loiseau H: Genetics and cytogenetics of multiple myeloma: a workshop report. Cancer Res. 2004, 64 (4): 1546-1558. 10.1158\/0008-5472.CAN-03-2876.","journal-title":"Cancer Res"},{"issue":"46","key":"1347_CR4","doi-asserted-by":"publisher","first-page":"6202","DOI":"10.1038\/sj.onc.1209910","volume":"25","author":"GA Calin","year":"2006","unstructured":"Calin GA, Croce CM: MicroRNAs and chromosomal abnormalities in cancer cells. Oncogene. 2006, 25 (46): 6202-6210. 10.1038\/sj.onc.1209910.","journal-title":"Oncogene"},{"issue":"15","key":"1347_CR5","doi-asserted-by":"publisher","first-page":"7390","DOI":"10.1158\/0008-5472.CAN-06-0800","volume":"66","author":"GA Calin","year":"2006","unstructured":"Calin GA, Croce CM: MicroRNA-cancer connection: the beginning of a new tale. Cancer Res. 2006, 66 (15): 7390-7394. 10.1158\/0008-5472.CAN-06-0800.","journal-title":"Cancer Res"},{"issue":"25","key":"1347_CR6","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.1182\/blood-2009-08-237495","volume":"114","author":"M Lionetti","year":"2009","unstructured":"Lionetti M, Biasiolo M, Agnelli L, Todoerti K, Mosca L, Fabris S, Sales G, Deliliers GL, Bicciato S, Lombardi L, Bortoluzzi S, Neri A: Identification of microRNA expression patterns and definition of a microRNA\/ mRNA regulatory network in distinct molecular groups of multiple myeloma. Blood. 2009, 114 (25): e20-26. 10.1182\/blood-2009-08-237495.","journal-title":"Blood"},{"key":"1347_CR7","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","volume":"116","author":"DP Bartel","year":"2004","unstructured":"Bartel DP: MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell. 2004, 116: 281-297. 10.1016\/S0092-8674(04)00045-5.","journal-title":"Cell"},{"key":"1347_CR8","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/nrg1379","volume":"5","author":"L He","year":"2004","unstructured":"He L, Hannon GJ: MicroRNAs: Small RNAs with a big role in gene regulation. Nature Rev Genet. 2004, 5: 522-531. 10.1038\/nrg1379.","journal-title":"Nature Rev Genet"},{"key":"1347_CR9","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1093\/nar\/gkl1032","volume":"35","author":"Z Yu","year":"2007","unstructured":"Yu Z, Jian Z, Shen SH, Purisima E, Wang E: Global analysis of microRNA target gene expression reveals that miRNA targets are lower expressed in mature mouse and Drosophila tissues than in the embryos. Nucleic Acids Res. 2007, 35: 152-164.","journal-title":"Nucleic Acids Res"},{"key":"1347_CR10","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/1476-4598-6-60","volume":"6","author":"WC Cho","year":"2007","unstructured":"Cho WC: OncomiRs: the discovery and progress of microRNAs in cancers. Mol Cancer. 2007, 6: 60-10.1186\/1476-4598-6-60.","journal-title":"Mol Cancer"},{"key":"1347_CR11","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/nrc1840","volume":"6","author":"A Esquela-Kerscher","year":"2006","unstructured":"Esquela-Kerscher A, Slack FJ: Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer. 2006, 6: 259-269. 10.1038\/nrc1840.","journal-title":"Nat Rev Cancer"},{"key":"1347_CR12","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3389\/fgene.2011.00022","volume":"2","author":"F Pichiorri","year":"2011","unstructured":"Pichiorri F, De Luca L, Aqeilan RI: MicroRNAs: new players in multiple myeloma. Front Genet. 2011, 2: 22-","journal-title":"Front Genet"},{"issue":"4","key":"1347_CR13","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1159\/000302889","volume":"123","author":"R Munker","year":"2010","unstructured":"Munker R, Liu CG, Taccioli C, Alder H, Heerema N: MicroRNA profiles of drug-resistant myeloma cell lines. Acta Haematol. 2010, 123 (4): 201-204. 10.1159\/000302889.","journal-title":"Acta Haematol"},{"issue":"35","key":"1347_CR14","doi-asserted-by":"publisher","first-page":"12885","DOI":"10.1073\/pnas.0806202105","volume":"105","author":"F Pichiorri","year":"2008","unstructured":"Pichiorri F, Suh SS, Ladetto M, Kuehl M, Palumbo T, Drandi D, Taccioli C, Zanesi N, Alder H, Hagan JP, Munker R, Volinia S, Boccadoro M, Garzon R, Palumbo A, Aqeilan RI, Croce CM: MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis. Proc Natl Acad Sci U S A. 2008, 105 (35): 12885-12890. 10.1073\/pnas.0806202105.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"1347_CR15","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1021\/pr201079y","volume":"11","author":"Q Xiong","year":"2012","unstructured":"Xiong Q, Zhong Q, Zhang J, Yang M, Li C, Zheng P, Bi LJ, Ge F: Identification of novel mir-21 target proteins in multiple myeloma cells by quantitative proteomics. J Proteome Res. 2012, 11 (4): 2078-2090. 10.1021\/pr201079y.","journal-title":"J Proteome Res"},{"issue":"4","key":"1347_CR16","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1182\/blood-2007-03-081133","volume":"110","author":"D L\u00f6ffler","year":"2007","unstructured":"L\u00f6ffler D, Brocke-Heidrich K, Pfeifer G, Stocsits C, Hackerm\u00fcller J, Kretzschmar AK, Burger R, Gramatzki M, Blumert C, Bauer K, Cvijic H, Ullmann AK, Stadler PF, Horn F: Interleukin-6 dependent survival of multiple myeloma cells involves the Stat3-mediated induction of microRNA-21 through a highly conserved enhancer. Blood. 2007, 110 (4): 1330-1333. 10.1182\/blood-2007-03-081133.","journal-title":"Blood"},{"issue":"23","key":"1347_CR17","doi-asserted-by":"publisher","first-page":"9895","DOI":"10.1158\/0008-5472.CAN-10-1546","volume":"70","author":"X Zhang","year":"2010","unstructured":"Zhang X, Gu L, Li J, Shah N, He J, Yang L, Hu Q, Zhou M: Degradation of MDM2 by the interaction between berberine and DAXX leads to potent apoptosis in MDM2-overexpressing cancer cells. Cancer Res. 2010, 70 (23): 9895-9904. 10.1158\/0008-5472.CAN-10-1546.","journal-title":"Cancer Res"},{"issue":"13","key":"1347_CR18","doi-asserted-by":"publisher","first-page":"5370","DOI":"10.1158\/0008-5472.CAN-08-0511","volume":"68","author":"MK Pandey","year":"2008","unstructured":"Pandey MK, Sung B, Kunnumakkara AB, Sethi G, Chaturvedi MM, Aggarwal BB: Berberine modifies cysteine 179 of IKBA kinase, suppresses nuclear factor-KB\u2013regulated antiapoptotic gene products, and potentiates apoptosis. Cancer Res. 2008, 68 (13): 5370-5379. 10.1158\/0008-5472.CAN-08-0511.","journal-title":"Cancer Res"},{"key":"1347_CR19","first-page":"407","volume":"21","author":"FS Yu","year":"2007","unstructured":"Yu FS, Yang JS, Lin HJ, Yu CS, Tan TW, Lin YT, Lin CC, Lu HF, Chung JG: Berberine inhibits WEHI-3 leukemia cells in vivo. In Vivo. 2007, 21: 407-412.","journal-title":"In Vivo"},{"key":"1347_CR20","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1093\/carcin\/bgl043","volume":"27","author":"SK Mantena","year":"2006","unstructured":"Mantena SK, Sharma SD, Katiyar SK: Berberine inhibits growth, induces G1 arrest and apoptosis in human epidermoid carcinoma A431 cells by regulating Cdki-Cdk-cyclin cascade, disruption of mitochondrial membrane potential and cleavage of caspase 3 and PARP. Carcinogenesis. 2006, 27: 2018-2027. 10.1093\/carcin\/bgl043.","journal-title":"Carcinogenesis"},{"key":"1347_CR21","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1211\/0022357011775901","volume":"53","author":"KV Anis","year":"2001","unstructured":"Anis KV, Rajeshkumar NV, Kuttan R: Inhibition of chemical carcinogenesis by berberine in rats and mice. J Pharm Pharmacol. 2001, 53: 763-768. 10.1211\/0022357011775901.","journal-title":"J Pharm Pharmacol"},{"key":"1347_CR22","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1159\/000226349","volume":"43","author":"H Nishino","year":"1986","unstructured":"Nishino H, Kitagawa K, Fujiki H, Iwashima A: Berberine sulfate inhibits tumor-promoting activity of teleocidin in two-stage carcinogenesis on mouse skin. Oncology. 1986, 43: 131-134. 10.1159\/000226349.","journal-title":"Oncology"},{"key":"1347_CR23","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1097\/CAD.0b013e328330d95b","volume":"20","author":"Y Sun","year":"2009","unstructured":"Sun Y, Xun K, Wang Y, Chen X: A systematic review of the anticancer properties of berberine, a natural product from Chinese herbs. Anticancer Drugs. 2009, 20: 757-769. 10.1097\/CAD.0b013e328330d95b.","journal-title":"Anticancer Drugs"},{"key":"1347_CR24","volume-title":"Bioinformatics","author":"X Wang","year":"2014","unstructured":"Wang X: Composition of seed sequence is a major determinant of microRNA targeting patterns. Bioinformatics. 2014, 2014 Feb 12. [Epub ahead of print]"},{"issue":"212","key":"1347_CR25","doi-asserted-by":"publisher","first-page":"212ra162","DOI":"10.1126\/scitranslmed.3006840","volume":"5","author":"V Rottiers","year":"2013","unstructured":"Rottiers V, Obad S, Petri A, McGarrah R, Lindholm MW, Black JC, Sinha S, Goody RJ, Lawrence MS, deLemos AS, Hansen HF, Whittaker S, Henry S, Brookes R, Najafi-Shoushtari SH, Chung RT, Whetstine JR, Gerszten RE, Kauppinen S, N\u00e4\u00e4r AM: Pharmacological inhibition of a microRNA family in nonhuman primates by a seed-targeting 8-mer antimiR. Sci Transl Med. 2013, 5 (212): 212ra162-10.1126\/scitranslmed.3006840.","journal-title":"Sci Transl Med"},{"issue":"4","key":"1347_CR26","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/ng.786","volume":"43","author":"S Obad","year":"2011","unstructured":"Obad S, dos Santos CO, Petri A, Heidenblad M, Broom O, Ruse C, Fu C, Lindow M, Stenvang J, Straarup EM, Hansen HF, Koch T, Pappin D, Hannon GJ, Kauppinen S: Silencing of microRNA families by seed-targeting tiny LNAs. Nat Genet. 2011, 43 (4): 371-378. 10.1038\/ng.786.","journal-title":"Nat Genet"},{"key":"1347_CR27","doi-asserted-by":"publisher","first-page":"4373","DOI":"10.1038\/onc.2008.72","volume":"27","author":"Z Lu","year":"2008","unstructured":"Lu Z, Liu M, Stribinskis V: MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene. Oncogene. 2008, 27: 4373-4379. 10.1038\/onc.2008.72.","journal-title":"Oncogene"},{"key":"1347_CR28","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1038\/sj.onc.1210856","volume":"27","author":"IA Asangani","year":"2008","unstructured":"Asangani IA, Rasheed SA, Nikolova DA, Leupold JH, Colburn NH, Post S, Allgayer H: MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene. 2008, 27: 2128-2136. 10.1038\/sj.onc.1210856.","journal-title":"Oncogene"},{"issue":"19","key":"1347_CR29","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1038\/sj.onc.1210083","volume":"26","author":"ML Si","year":"2007","unstructured":"Si ML, Zhu S, Wu H, Lu Z, Wu F, Mo YY: miR-21-mediated tumor growth. Oncogene. 2007, 26 (19): 2799-2803. 10.1038\/sj.onc.1210083.","journal-title":"Oncogene"},{"issue":"7311","key":"1347_CR30","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/nature09284","volume":"467","author":"PP Medina","year":"2010","unstructured":"Medina PP, Nolde M, Slack FJ: OncomiR addiction in an vivo model of microRNA-21-induced pre-B-cell lymphoma. Nature. 2010, 467 (7311): 86-90. 10.1038\/nature09284.","journal-title":"Nature"},{"key":"1347_CR31","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ymeth.2007.11.001","volume":"44","author":"CC Esau","year":"2008","unstructured":"Esau CC: Inhibition of microRNA with antisense oligonucleotides. Methods. 2008, 44: 55-60. 10.1016\/j.ymeth.2007.11.001.","journal-title":"Methods"},{"key":"1347_CR32","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1093\/nar\/gki200","volume":"33","author":"AM Cheng","year":"2005","unstructured":"Cheng AM, Byrom MW, Shelton J, Ford LP: Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res. 2005, 33: 1290-1297. 10.1093\/nar\/gki200.","journal-title":"Nucleic Acids Res"},{"key":"1347_CR33","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1038\/sj.gt.3302654","volume":"13","author":"J Weiler","year":"2005","unstructured":"Weiler J, Hunziker J, Hall J: Anti-miRNA oligonucleotides (AMOs): ammunition to target miRNAs implicated in human disease?. Gene Ther. 2005, 13: 496-502.","journal-title":"Gene Ther"},{"issue":"1","key":"1347_CR34","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/j.1582-4934.2008.00556.x","volume":"13","author":"AM Krichevsky","year":"2009","unstructured":"Krichevsky AM, Gabriely G: miR-21: a small multi-faceted RNA. J Cell Mol Med. 2009, 13 (1): 39-53.","journal-title":"J Cell Mol Med"},{"issue":"Pt 4","key":"1347_CR35","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1042\/BST0370918","volume":"37","author":"SD Selcuklu","year":"2009","unstructured":"Selcuklu SD, Donoghue MT, Spillane C: miR-21 as a key regulator of oncogenic processes. Biochem Soc Trans. 2009, 37 (Pt 4): 918-925.","journal-title":"Biochem Soc Trans"},{"issue":"6","key":"1347_CR36","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1042\/BC20080191","volume":"101","author":"B Lankat-Buttgereit","year":"2009","unstructured":"Lankat-Buttgereit B, G\u00f6ke R: The tumour suppressor Pdcd4: recent advances in the elucidation of function and regulation. Biol Cell. 2009, 101 (6): 309-317. 10.1042\/BC20080191.","journal-title":"Biol Cell"},{"issue":"5798","key":"1347_CR37","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1126\/science.1134031","volume":"314","author":"N Sonenberg","year":"2006","unstructured":"Sonenberg N, Pause A: Protein synthesis and oncogenesis meet again. Science. 2006, 314 (5798): 428-429. 10.1126\/science.1134031.","journal-title":"Science"},{"issue":"3","key":"1347_CR38","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1042\/BSR20110045","volume":"32","author":"JH Leupold","year":"2012","unstructured":"Leupold JH, Asangani IA, Mudduluru G, Allgayer H: Promoter cloning and characterization of the human programmed cell death protein 4 (pdcd4) gene: evidence for ZBP-89 and Sp-binding motifs as essential Pdcd4-regulators. Biosci Rep. 2012, 32 (3): 281-297. 10.1042\/BSR20110045.","journal-title":"Biosci Rep"},{"issue":"3","key":"1347_CR39","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s00432-011-1121-y","volume":"138","author":"X Li","year":"2012","unstructured":"Li X, Xin S, Yang D, Li X, He Z, Che X, Wang J, Chen F, Wang X, Song X: Down-regulation of PDCD4 expression is an independent predictor of poor prognosis in human renal cell carcinoma patients. J Cancer Res Clin Oncol. 2012, 138 (3): 529-535. 10.1007\/s00432-011-1121-y.","journal-title":"J Cancer Res Clin Oncol"},{"key":"1347_CR40","doi-asserted-by":"publisher","first-page":"3712","DOI":"10.1038\/sj.onc.1206433","volume":"22","author":"HS Yang","year":"2003","unstructured":"Yang HS, Knies JL, Stark C, Colburn NH: Pdcd4 suppresses tumor phenotype in JB6 cells by inhibiting AP-1 transactivation. Oncogene. 2003, 22: 3712-3720. 10.1038\/sj.onc.1206433.","journal-title":"Oncogene"},{"issue":"45","key":"1347_CR41","doi-asserted-by":"publisher","first-page":"7484","DOI":"10.1038\/sj.onc.1208064","volume":"23","author":"N Bitomsky","year":"2004","unstructured":"Bitomsky N, B\u00f6hm M, Klempnauer KH: Transformation suppressor protein Pdcd4 interferes with JNK-mediated phosphorylation of c-Jun and recruitment of the coactivator p300 by c-Jun. Oncogene. 2004, 23 (45): 7484-7493. 10.1038\/sj.onc.1208064.","journal-title":"Oncogene"},{"issue":"31","key":"1347_CR42","doi-asserted-by":"publisher","first-page":"4550","DOI":"10.1038\/sj.onc.1210234","volume":"26","author":"JH Leupold","year":"2007","unstructured":"Leupold JH, Yang HS, Colburn NH, Asangani I, Post S, Allgayer H: Tumor suppressor Pdcd4 inhibits invasion\/intravasation and regulates urokinase receptor (u-PAR) gene expression via Sp-transcription factors. Oncogene. 2007, 26 (31): 4550-4562. 10.1038\/sj.onc.1210234.","journal-title":"Oncogene"},{"issue":"35","key":"1347_CR43","doi-asserted-by":"publisher","first-page":"4820","DOI":"10.1038\/onc.2008.115","volume":"27","author":"N Bitomsky","year":"2008","unstructured":"Bitomsky N, Wethkamp N, Marikkannu R, Klempnauer KH: siRNA-mediated knockdown of Pdcd4 expression causes upregulation of p21(Waf1\/Cip1) expression. Oncogene. 2008, 27 (35): 4820-9. 10.1038\/onc.2008.115. Epub 2008 Apr 21","journal-title":"Oncogene"},{"issue":"50","key":"1347_CR44","doi-asserted-by":"publisher","first-page":"42855","DOI":"10.1074\/jbc.M111.269456","volume":"286","author":"L Wedeken","year":"2011","unstructured":"Wedeken L, Singh P, Klempnauer KH: Tumor suppressor protein Pdcd4 inhibits translation of p53 mRNA. J Biol Chem. 2011, 286 (50): 42855-62. 10.1074\/jbc.M111.269456. Epub 2011 Oct 27","journal-title":"J Biol Chem"},{"key":"1347_CR45","first-page":"7081","volume":"63","author":"M Fraser","year":"2003","unstructured":"Fraser M, Leung BM, Yan X, Dan HC, Cheng JQ, Tsang BK: p53 is a determinant of X-linked inhibitor of apoptosis protein\/Akt-mediated chemoresistance in human ovarian cancer cells. Cancer Res. 2003, 63: 7081-7088.","journal-title":"Cancer Res"},{"key":"1347_CR46","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/1477-7827-1-66","volume":"1","author":"M Fraser","year":"2003","unstructured":"Fraser M, Leung B, Jahani-Asl A, Yan X, Thompson WE, Tsang BK: Chemoresistance in human ovarian cancer: the role of apoptotic regulators. Reprod Biol Endocrinol. 2003, 1: 66-10.1186\/1477-7827-1-66.","journal-title":"Reprod Biol Endocrinol"},{"key":"1347_CR47","first-page":"157","volume-title":"Set9, NF-\u03baB, and microRNA-21 mediate berberine-induced apoptosis of human multiple myeloma cells","author":"HY Hu","year":"2013","unstructured":"Hu HY, Li KP, Wang XJ, Liu Y, Lu ZG, Dong RH, Guo HB, Zhang MX: Set9, NF-\u03baB, and microRNA-21 mediate berberine-induced apoptosis of human multiple myeloma cells. 2013, 34 (1): 157-166."}],"container-title":["BMC Systems Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1752-0509-8-82.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T09:16:42Z","timestamp":1630574202000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcsystbiol.biomedcentral.com\/articles\/10.1186\/1752-0509-8-82"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,7]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["1347"],"URL":"https:\/\/doi.org\/10.1186\/1752-0509-8-82","relation":{},"ISSN":["1752-0509"],"issn-type":[{"value":"1752-0509","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,7]]},"assertion":[{"value":"18 February 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"82"}}